BioMed Commercialization Center
2F., No.8, Sec.2, Sheng Yi Rd., Zhubei City, Hsinchu County 30261, Taiwan
About us
The BioMed Commercialization Center is dedicated to translating high-quality academia research into products of great clinical value. Our Medtech team provides companies one-stop support to accelerate through hurdles in commercialization and maximize global value. We provide startup support in value-adding (technology/IP/clinical), prototyping and commercialization. We are setup as a trusted partner for academic and industry clients’ entry into Taiwan’s fast-growing medtech sectors.
The BioMed Commercialization Center is dedicated to translating high-quality academia research into products of great clinical value. Our Medtech team provides companies one-stop support to accelerate through hurdles in commercialization and maximize global value. We provide startup support in value-adding (technology/IP/clinical), prototyping and commercialization. We are setup as a trusted partner for academic and industry clients’ entry into Taiwan’s fast-growing medtech sectors.
Products
Precision Blood Test Kit for Screening for Breast Cancer
- Breast cancer tops the global incidence chart for female cancers. While mammography is the most common screening test for breast cancer, some 71% of its results are false positives. What this entails is undeniably a waste of medical resources.
- The team has thus developed a blood test kit to screen for breast cancer. Qualitative testing is done on cell-free DNA with a view to identifying DNA methylation that is specific to breast cancer. In addition to accuracy of up to 90%, this approach has the capacity for detecting breast cancer early on (stage 0, I, and II). Physicians can thus better help women of 20-80 determine if they have breast cancer.
- Complement mammography to enhance accuracy so that patients can secure precise diagnosis and proper treatment early on.